| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |